The Zirela Nebulizer Handset is a device from PARI's eFlow® Technology platform that is specifically optimized for the nebulization of Quinsair 240 mg Nebulizer Solution. For detailed information about Quinsair please refer to the package leaflet of the medicine.
Intended purpose
The Zirela Nebulizer Handset with an eBase® or eTrack® Controller is intended to administer Quinsair as an aerosol for inhalation.
Indication
The Zirela Nebulizer Handset is indicated to administer Quinsair to treat lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF).
Contraindication
For the Zirela Nebulizer Handset no contraindication is known to PARI Pharma GmbH. Take note of contraindications of the medicine in the Quinsair package leaflet.
Use of the Nebulizer Handset
The Zirela Nebulizer Handset must only be used in accordance with its intended purpose. For reasons of hygiene and to avoid cross-infections, the Zirela Nebulizer Handset must only be used by one patient.
© 2025 PARI GmbH Spezialisten für effektive Inhalation